AS
Astec Lifesciences Ltd (ASTEC)
₹708.60
Mkt cap
₹1,619 Cr
P/E ratio
—
P/B
4.05
Div yield
0.00%
ROE
−25.20%
ROCE
−5.44%
EPS (TTM)
—
Book value
₹175
52W range
513–942
Sector
Commodities
Price history
Previous close
The Company is into manufacturing of agrochemical active ingredients (technical), bulk and formulations, intermediate products and it sells its products in India as well as exports them to approximately 24 countries. Astec also has undertaken a number of custom synthesis projects, for its clients in Europe, Japan and the US. It is present only in business to business sale (B2B). [1] [2] [3]
NSE ASTECBSE 533138
Health check
Cautious
ProfitabilityWeak
GrowthLow
TechnicalsNeutral
52-week range
−24.76% from high₹709
₹513+38.02% from low₹942
Current
₹708.60
Prev close
₹722.75
Day
−1.96%
Price performance
1D
−1.65%
1W
−2.47%
1M
+26.39%
3M
+0.13%
6M
+31.48%
1Y
−13.28%
YTD
−0.92%
Financials
Revenue, profit & margin
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 143 | 111 | 51 | 154 | 69 | 99 | 94 | 120 | 91 | 74 | 125 | 159 | 84 | |
| Expenses | 140 | 114 | 69 | 141 | 116 | 118 | 100 | 114 | 102 | 80 | 121 | 149 | 84 | |
| Operating Profit | 3 | -3 | -18 | 13 | -46 | -20 | -6 | 6 | -11 | -7 | 4 | 9 | -1 | |
| OPM % | 2.2% | -3.1% | -36% | 8% | -67% | -20% | -6% | 4.6% | -12% | -9% | 3.2% | 6% | -0.8% | |
| Other Income | 2 | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 1 | 1 | -1 | 3 | 1 | |
| Interest | 6 | 6 | 6 | 7 | 7 | 9 | 10 | 10 | 11 | 8 | 7 | 8 | 8 | |
| Depreciation | 9 | 9 | 9 | 9 | 9 | 11 | 11 | 12 | 11 | 10 | 11 | 12 | 11 | |
| Profit before tax | -11 | -18 | -32 | -1 | -62 | -39 | -25 | -16 | -33 | -24 | -16 | -8 | -19 | |
| Tax % | -26% | -24% | -24% | 4% | -36% | 0% | 61% | 3% | 0% | 0% | 0% | -2% | -0% | |
| Net Profit | -8 | -13 | -24 | -1 | -40 | -39 | -40 | -16 | -33 | -24 | -16 | -8 | -19 | |
| EPS in Rs | -3.66 | -6.00 | -10.86 | -0.43 | -17.73 | -17.21 | -18.03 | -7.18 | -14.75 | -10.96 | -7.05 | -3.48 | -8.40 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −4.13% · closed higher next day 0 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 31 Jul '26◦ |
| Earnings day | −4.13% |
| +1 day | −5.05% |
| +5 days | −5.29% |
| +15 days | −9.56% |
| +30 days | +2.80% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Results analysis
Shareholding
as of Jun 202671.97%Promoter
Promoters71.97%
FIIs0.01%0.02
DIIs3.33%
Public24.69%0.02
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| UPL | ₹580.00 | 24.77 | 48,946 | 1.03% | −73 | +92.63% | 10,181 | +10.47% | 10.11% |
| P I Industries | ₹2,366.80 | 33.25 | 35,909 | 0.63% | 244 | −38.95% | 1,702 | −10.43% | 14.99% |
| Sumitomo Chemi. | ₹460.85 | 40.27 | 23,003 | 0.28% | 217 | +9.30% | 1,054 | +0.57% | 23.48% |
| Bayer Crop Sci. | ₹3,779.50 | 23.20 | 16,986 | 3.97% | 322 | +15.39% | 1,835 | −4.16% | 29.14% |
| Sharda Cropchem | ₹743.10 | 10.71 | 6,704 | 2.02% | 88 | −38.34% | 1,074 | +9.03% | 30.25% |
| Dhanuka Agritech | ₹973.30 | 16.19 | 4,339 | 0.21% | 36 | −34.59% | 462 | −12.56% | 23.76% |
| Rallis India | ₹203.80 | 17.35 | 3,963 | 1.47% | 125 | +30.04% | 1,022 | +6.79% | 14.14% |
| Astec Lifescienc | ₹726.70 | — | 1,619 | 0.00% | −19 | +43.34% | 84 | −8.26% | −5.44% |
| Median: 25 Co. | ₹276.15 | 21.45 | 1,619 | 0.21% | 23 | +16.90% | 383 | −3.21% | 14.99% |
Filings
Annual reports15
Concall transcripts6
Credit ratings6
Announcements4
Response To BSE Query Dated 18.09.2026 18 Sep - Astec Lifesciences replies to BSE volume inquiry, saying no undisclosed developments exist.Clarification sought from Astec Lifesciences Ltd 18 Sep - Exchange has sought clarification from Astec Lifesciences Ltd on September 18, 2026, with reference to Movement in Volume.Response To BSE E-Mail Seeking Clarification On Price Movement 11 Sep - Astec Lifesciences confirms no undisclosed developments behind recent volume increase.Reply To BSE Query Regarding Volume Movement Dated September 9, 2026 9 Sep - Astec Lifesciences says no undisclosed developments explain recent share volume rise.